… the neurodegenerative process as well as levodopa-induced dyskinesia, and that anti-inflammatory/neuromodulatory drugs …

… necessary for proper motor control have died, leading to dyskinesias that make it difficult to walk and talk. A …

… time? Or that everyone who takes it eventually develops dyskinesia (involuntary, uncontrolled movements)? These …

… MJFF for a clinical trial to test a potential therapy for dyskinesias, a major priority research area for MJFF. The … receptor in the brain called mGluR5, a promising target for dyskinesia drugs that MJFF has been investing in since 2005. …

… much medication, including one which is sometimes caused by dyskinesia, the uncontrollable movements often associated …

… AFQ056/mavoglurant for Parkinson’s disease levodopa-induced dyskinesia. His current position is vice president of …